LSL Pharma Group Inc. (TSXV:LSL)
Canada · Delayed Price · Currency is CAD 0.3300
0.00 (0.00%)
Jun 10, 2026, 1:17 PM EST
LSL Pharma Group Market Cap
LSL Pharma Group has a market cap or net worth of CAD 40 million as of June 10, 2026. Its market cap has decreased by -12.34% in one year.
Market Cap
40.00M
Enterprise Value
61.61M
Revenue
26.80M
Ranking
n/a
PE Ratio
14.54
Stock Price
0.33
Market Cap Chart
Since March 2, 2023, LSL Pharma Group's market cap has decreased from 61.67M to 40.00M, a decrease of -35.13%. That is a compound annual growth rate of -12.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 40.00M | -5.71% |
| Dec 31, 2025 | 42.43M | -10.43% |
| Dec 31, 2024 | 47.37M | 18.48% |
| Dec 29, 2023 | 39.98M | -35.17% |
| Mar 2, 2023 | 61.67M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Decibel Cannabis Company | 66.36M |
| Planet 13 Holdings | 65.72M |
| Vext Science | 64.40M |
| BioNxt Solutions | 52.65M |
| C21 Investments | 47.84M |
| Optimi Health | 41.01M |
| ZYUS Life Sciences | 39.86M |
| iAnthus Capital Holdings | 34.86M |